Published in Lancet on September 04, 1999
Prevention of mother-to-child transmission of HIV in Africa: successes and challenges in scaling-up a nevirapine-based program in Lusaka, Zambia. AIDS (2003) 4.82
The Demand for, and Impact of, Learning HIV Status. Am Econ Rev (2008) 3.25
Comparison of two strategies for administering nevirapine to prevent perinatal HIV transmission in high-prevalence, resource-poor settings. J Acquir Immune Defic Syndr (2003) 2.97
Is antenatal syphilis screening still cost effective in sub-Saharan Africa. Sex Transm Infect (2003) 2.77
HIV prevention costs and program scale: data from the PANCEA project in five low and middle-income countries. BMC Health Serv Res (2007) 2.55
Determinants of male involvement in the prevention of mother-to-child transmission of HIV programme in Eastern Uganda: a cross-sectional survey. Reprod Health (2010) 2.19
The 50th anniversary of the Declaration of Helsinki: progress but many remaining challenges. JAMA (2013) 2.16
Sensitivity and specificity of human immunodeficiency virus rapid serologic assays and testing algorithms in an antenatal clinic in Abidjan, Ivory Coast. J Clin Microbiol (2001) 2.05
The standard of care debate: can research in developing countries be both ethical and responsive to those countries' health needs? Am J Public Health (2004) 1.88
Role of traditional birth attendants in preventing perinatal transmission of HIV. BMJ (2002) 1.72
Outputs, cost and efficiency of public sector centres for prevention of mother to child transmission of HIV in Andhra Pradesh, India. BMC Health Serv Res (2008) 1.69
Effect of nevirapine toxicity on choice of perinatal HIV prevention strategies. Am J Public Health (2002) 1.56
Couples' voluntary counselling and testing and nevirapine use in antenatal clinics in two African capitals: a prospective cohort study. J Int AIDS Soc (2010) 1.54
Ensuring a public health impact of programs to reduce HIV transmission from mothers to infants: the place of voluntary counseling and testing. Am J Public Health (2002) 1.54
Cheaper antiretrovirals to treat AIDS in South Africa. They are at their most cost effective in preventing mother to child transmission. BMJ (2000) 1.54
Maternal malaria and perinatal HIV transmission, western Kenya. Emerg Infect Dis (2004) 1.45
Cost-effectiveness of rapid syphilis screening in prenatal HIV testing programs in Haiti. PLoS Med (2007) 1.41
Research translation to inform national health policies: learning from multiple perspectives in Uganda. BMC Int Health Hum Rights (2011) 1.16
Prevention of mother-to-child transmission of HIV: cost-effectiveness of antiretroviral regimens and feeding options in Rwanda. PLoS One (2013) 1.14
Cost-effectiveness of models for prevention of vertical HIV transmission - voluntary counseling and testing and choices of drug regimen. Cost Eff Resour Alloc (2005) 1.09
Aiming for zero: preventing mother-to-child transmission of HIV. CMAJ (2002) 1.09
Sensitive oligonucleotide ligation assay for low-level detection of nevirapine resistance mutations in human immunodeficiency virus type 1 quasispecies. J Clin Microbiol (2007) 1.08
Universal nevirapine upon presentation in labor to prevent mother-to-child HIV transmission in high prevalence settings. AIDS (2004) 1.07
The cost-effectiveness of preventing mother-to-child transmission of HIV in low- and middle-income countries: systematic review. Cost Eff Resour Alloc (2011) 1.06
Combining evidence and values in priority setting: testing the balance sheet method in a low-income country. BMC Health Serv Res (2007) 1.01
Cost-effectiveness of medical interventions to prevent cardiovascular disease in a sub-Saharan African country--the case of Tanzania. Cost Eff Resour Alloc (2007) 0.99
Global impact of human immunodeficiency virus and AIDS. Clin Microbiol Rev (2001) 0.94
Optimizing PMTCT service delivery in rural North-Central Nigeria: protocol and design for a cluster randomized study. Contemp Clin Trials (2013) 0.92
Perinatal HIV transmission and the cost-effectiveness of screening at 14 weeks gestation, at the onset of labour and the rapid testing of infants. BMC Infect Dis (2008) 0.91
Protein adducts as prospective biomarkers of nevirapine toxicity. Chem Res Toxicol (2010) 0.88
Assessing the efficiency of mother-to-child HIV prevention in low- and middle-income countries using data envelopment analysis. Health Care Manag Sci (2012) 0.82
Global discourses and experiential speculation: Secondary and tertiary graduate Malawians dissect the HIV/AIDS epidemic. J Int AIDS Soc (2011) 0.79
The cost-effectiveness of different feeding patterns combined with prompt treatments for preventing mother-to-child HIV transmission in South Africa: estimates from simulation modeling. PLoS One (2014) 0.77
HIVNET nevirapine trials. Lancet (1999) 0.77
Evaluating Cost-effectiveness of Interventions That Affect Fertility and Childbearing: How Health Effects Are Measured Matters. Med Decis Making (2015) 0.77
Use of DALYs in economic analyses on interventions for infectious diseases: a systematic review. Epidemiol Infect (2014) 0.77
Lack of effect from a previous single dose of nevirapine on virologic and immunologic responses after 6 months of antiretroviral regimens containing either efavirenz or lopinavir-ritonavir. Pharmacotherapy (2011) 0.75
HIVNET nevirapine trials. Lancet (1999) 0.75
Nevirapine: an option for preventing as well as treating paediatric HIV infection. Afr Health Sci (2001) 0.75
Sojourn in South Africa. Can Fam Physician (2002) 0.75
AIDS and HIV Infection after Thirty Years. AIDS Res Treat (2013) 0.75
Intrapartum and neonatal single-dose nevirapine compared with zidovudine for prevention of mother-to-child transmission of HIV-1 in Kampala, Uganda: HIVNET 012 randomised trial. Lancet (1999) 18.20
Prevention of mother-to-child HIV transmission in resource-poor countries: translating research into policy and practice. JAMA (2000) 10.17
Selection and fading of resistance mutations in women and infants receiving nevirapine to prevent HIV-1 vertical transmission (HIVNET 012). AIDS (2001) 5.31
Risk factors for perinatal transmission of human immunodeficiency virus type 1 in women treated with zidovudine. Pediatric AIDS Clinical Trials Group Study 185 Team. N Engl J Med (1999) 4.12
The relation of virologic and immunologic markers to clinical outcomes after nucleoside therapy in HIV-infected adults with 200 to 500 CD4 cells per cubic millimeter. AIDS Clinical Trials Group Study 175 Virology Study Team. N Engl J Med (1996) 4.03
Do corals lie about their age? Some demographic consequences of partial mortality, fission, and fusion. Science (1980) 2.84
Hurricane Allen's Impact on Jamaican Coral Reefs. Science (1981) 2.76
Thalidomide for the treatment of oral aphthous ulcers in patients with human immunodeficiency virus infection. National Institute of Allergy and Infectious Diseases AIDS Clinical Trials Group. N Engl J Med (1997) 2.55
Identification of the K103N resistance mutation in Ugandan women receiving nevirapine to prevent HIV-1 vertical transmission. AIDS (2000) 2.49
A whole blood immunoassay using gold nanoshells. Anal Chem (2003) 2.45
A phase I/II study of the safety and pharmacokinetics of nevirapine in HIV-1-infected pregnant Ugandan women and their neonates (HIVNET 006). AIDS (1999) 2.23
Crack, sex, and STD. Sex Transm Dis (1991) 2.14
The cost-effectiveness of voluntary counseling and testing of hospital inpatients for HIV infection. JAMA (1994) 2.08
Obstetrical factors and the transmission of human immunodeficiency virus type 1 from mother to child. The Women and Infants Transmission Study. N Engl J Med (1996) 2.08
Reducing infection transmission in solid organ transplantation through donor nucleic acid testing: a cost-effectiveness analysis. Am J Transplant (2013) 2.02
Predictive value of quantitative plasma HIV RNA and CD4+ lymphocyte count in HIV-infected infants and children. JAMA (1998) 2.00
Comparative stabilities of quantitative human immunodeficiency virus RNA in plasma from samples collected in VACUTAINER CPT, VACUTAINER PPT, and standard VACUTAINER tubes. J Clin Microbiol (1995) 1.98
Evaluation of a home-based intervention program to reduce infant passive smoking and lower respiratory illness. J Behav Med (1994) 1.97
Impact of human immunodeficiency virus type 1 (hiv-1) subtype on women receiving single-dose nevirapine prophylaxis to prevent hiv-1 vertical transmission (hiv network for prevention trials 012 study). J Infect Dis (2001) 1.93
Cost and efficiency of HIV voluntary counselling and testing centres in Andhra Pradesh, India. Natl Med J India (2005) 1.86
Performance characteristics of serologic tests for human immunodeficiency virus type 1 (HIV-1) antibody among Minnesota blood donors. Public health and clinical implications. Ann Intern Med (1989) 1.84
Diversity and extinction of tropical american mollusks and emergence of the isthmus of panama. Science (1993) 1.79
Chromatin fractionation procedure that yields nucleosomes containing near-stoichiometric amounts of high mobility group nonhistone chromosomal proteins. Biochemistry (1979) 1.72
A rapid manual method for CD4+ T-cell quantitation for use in developing countries. AIDS (1993) 1.63
Evolutionary significance of morphospecies: a test with cheilostome bryozoa. Science (1990) 1.62
Association of maternal drug use during pregnancy with maternal HIV culture positivity and perinatal HIV transmission. AIDS (1996) 1.59
Zidovudine, didanosine, or both as the initial treatment for symptomatic HIV-infected children. AIDS Clinical Trials Group (ACTG) Study 152 Team. N Engl J Med (1997) 1.56
Geographic mobility and children's emotional/behavioral adjustment and school functioning. Pediatrics (1994) 1.53
A critical analysis of the use of radiation inactivation to measure the mass of protein. Radiat Res (1995) 1.52
Performance of the applied biosystems ViroSeq human immunodeficiency virus type 1 (HIV-1) genotyping system for sequence-based analysis of HIV-1 in pediatric plasma samples. J Clin Microbiol (2001) 1.47
School achievement and absence in children with chronic health conditions. J Pediatr (1985) 1.46
Ion transport induced by light and antibiotics IN CHROMATOPHORES FROM Rhodospirillum rubrum. Eur J Biochem (1968) 1.42
Early cognitive and motor development among infants born to women infected with human immunodeficiency virus. Women and Infants Transmission Study Group. Pediatrics (2000) 1.42
The cost-effectiveness of HIV testing of physicians and dentists in the United States. JAMA (1994) 1.39
Is post-exposure prophylaxis affordable? AIDS (2000) 1.39
Child care arrangements and repeated ear infections in young children. Am J Public Health (1993) 1.38
Tuberculosis knowledge, attitudes and health-seeking behaviour in rural Uganda. Int J Tuberc Lung Dis (2011) 1.35
Electron flow to dimethylsulphoxide or trimethylamine-N-oxide generates a membrane potential in Rhodopseudomonas capsulata. Arch Microbiol (1983) 1.35
Neurodevelopmental outcomes of Ugandan infants with human immunodeficiency virus type 1 infection. Pediatrics (1997) 1.33
Recent brachiopod-coralline sponge communities and their paleoecological significance. Science (1971) 1.27
Maternal and infant factors predicting disease progression in human immunodeficiency virus type 1-infected infants. Women and Infants Transmission Study Group. Pediatrics (2000) 1.27
Comparison of nevirapine (NVP) resistance in Ugandan women 7 days vs. 6-8 weeks after single-dose nvp prophylaxis: HIVNET 012. AIDS Res Hum Retroviruses (2004) 1.25
The kinetics of light induced carotenoid changes in Rhodopseudomonas spheroides and their relation to electrical field generation across the chromatophore membrane. Eur J Biochem (1971) 1.24
Ecology of passive smoking by young infants. J Pediatr (1989) 1.20
Performance of Applied Biosystems ViroSeq HIV-1 Genotyping System for sequence-based analysis of non-subtype B human immunodeficiency virus type 1 from Uganda. J Clin Microbiol (2001) 1.19
Community unity? Science (1994) 1.18
Predictors of virologic and clinical outcomes in HIV-1-infected patients receiving concurrent treatment with indinavir, zidovudine, and lamivudine. AIDS Clinical Trials Group Protocol 320. Ann Intern Med (2001) 1.18
New taxonomy and niche partitioning on coral reefs: jack of all trades or master of some? Trends Ecol Evol (1994) 1.15
Non-isotopic polymerase chain reaction methods for the detection of HIV-1 in Ugandan mothers and infants. AIDS (1991) 1.12
Cost-effectiveness of the female condom in preventing HIV and STDs in commercial sex workers in rural South Africa. Soc Sci Med (2001) 1.12
Pentoxifylline therapy in human immunodeficiency virus-seropositive persons with tuberculosis: a randomized, controlled trial. J Infect Dis (1996) 1.12
Ecological effects of a major oil spill on panamanian coastal marine communities. Science (1989) 1.11
Combination nucleoside analog reverse transcriptase inhibitor(s) plus nevirapine, nelfinavir, or ritonavir in stable antiretroviral therapy-experienced HIV-infected children: week 24 results of a randomized controlled trial--PACTG 377. Pediatric AIDS Clinical Trials Group 377 Study Team. AIDS Res Hum Retroviruses (2000) 1.11
Thermodynamic and kinetic characterization of electron transfer components in situ in Rhodopseudomonas spheroides and Rhodospirillum rubrum. Eur J Biochem (1972) 1.11
Analysis of HIV type 1 protease and reverse transcriptase in antiretroviral drug-naive Ugandan adults. AIDS Res Hum Retroviruses (2000) 1.11
Risk factors and cumulative incidence of anaemia among human immunodeficiency virus-infected children in Uganda. Ann Trop Paediatr (2002) 1.10
Comparison of infant mortality among twins and singletons: United States 1960 and 1983. Am J Epidemiol (1991) 1.09
Pelvic inflammatory disease: metaanalysis of antimicrobial regimen efficacy. J Infect Dis (1993) 1.09
Undiagnosed HIV infection in acute care hospitals. N Engl J Med (1992) 1.07
Prognostic value of plasma human immunodeficiency virus type 1 (HIV-1) RNA levels in patients with advanced HIV-1 disease and with little or no prior zidovudine therapy. AIDS Clinical Trials Group Protocol 116A/116B/117 Team. J Infect Dis (1996) 1.07
Analysis of human immunodeficiency virus type 1 drug resistance in children receiving nucleoside analogue reverse-transcriptase inhibitors plus nevirapine, nelfinavir, or ritonavir (Pediatric AIDS Clinical Trials Group 377). J Infect Dis (2001) 1.07
Serologic and phylogenetic characterization of HIV-1 subtypes in Uganda. AIDS (1997) 1.06
Energy-linked reduction of nicotinamide adenine dinucleotides in cells of Rhodospirillum rubrum. Biochem Biophys Res Commun (1968) 1.06
Performance characteristics of the QUANTIPLEX HIV-1 RNA 3.0 assay for detection and quantitation of human immunodeficiency virus type 1 RNA in plasma. J Clin Microbiol (2000) 1.05
The identification of cytochromes involved in the transfer of electrons to the periplasmic NO3- reductase of Rhodobacter capsulatus and resolution of a soluble NO3(-)-reductase--cytochrome-c552 redox complex. Eur J Biochem (1990) 1.05
Identification of diverse HIV type 1 subtypes and dual HIV type 1 infection in pregnant Ugandan women. AIDS Res Hum Retroviruses (2000) 1.04
Variability and prognostic values of virologic and CD4 cell measures in human immunodeficiency virus type 1-infected patients with 200-500 CD4 cells/mm(3) (ACTG 175). AIDS Clinical Trials Group Protocol 175 Team. J Infect Dis (1998) 1.04
The kinetic and redox potentiometric resolution of the carotenoid shifts in Rhodopseudomonas spheroides chromatophores: their relationship to electric field alterations in electron transport and energy coupling. Biochim Biophys Acta (1973) 1.03
Which unruptured cerebral aneurysms should be treated? A cost-utility analysis. Neurology (1999) 1.02
Nasopharyngeal aspiration for diagnosis of pulmonary tuberculosis. Arch Dis Child (2006) 1.02
Preschool risk factors as predictors of early school performance. J Dev Behav Pediatr (1986) 1.01
Interaction between the respiratory and photosynthetic electron transport chains of intact cells of Rhodopseudomonas capsulata mediated by membrane potential. Eur J Biochem (1983) 1.00
Neurodevelopmental outcomes of Ugandan infants with HIV infection: an application of growth curve analysis. Health Psychol (1999) 1.00
Adherence to tablet and liquid formulations of antiretroviral medication for paediatric HIV treatment at an urban clinic in Uganda. Ann Trop Paediatr (2011) 0.99
Pelvic inflammatory disease. Key treatment issues and options. JAMA (1991) 0.98
The value of urine testing for verifying adherence to anti-tuberculosis chemotherapy in children and adults in Uganda. Int J Tuberc Lung Dis (2002) 0.98